Intrexon reported $287K in Stock for its fiscal quarter ending in December of 2022.





Stock Change Date
Amgen USD 6.39B 169M Sep/2026
Anika Therapeutics USD 28.56M 5.73M Jun/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
AstraZeneca USD 6.93B 362M Jun/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Gilead Sciences USD 1.9B 57M Sep/2026
GlaxoSmithKline GBP 6.28B 125M Jun/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Incyte USD 134.25M 21.71M Sep/2026
Intrexon USD 287K 68K Dec/2022
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 14.51M 4.24M Sep/2026
MacroGenics USD 9.5M 1.59M Mar/2026
MannKind USD 48.47M 4.05M Sep/2026
Merck USD 6.16B 43M Sep/2026
Novartis USD 6.1B 116M Sep/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Thermo Fisher Scientific USD 5.64B 16M Sep/2026
Veracyte USD 25.82M 3.16M Sep/2026